Cutaneous Lupus Erythematosus (CLE) research hub

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

This study is testing a new medicine, VENT-03, for adults with a skin condition called cutaneous lupus (CLE), who may also have systemic lupus (SLE). Researchers want to see if VENT-03 helps reduce symptoms and if it's safe.